Additional file 5 of Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape

Additional file 5. Comparison of the prevalence of frequent pathogenic mutations observed in our cohort against the TCGA data and a Japanese cohort study [19–21]